In 1981 was created Genzyme, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Cambridge.
This Genzyme works on 46 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2008. The real fund results show that this Corporate Investor is 55 percentage points more often commits exit comparing to other companies. The increased amount of exits for fund were in 2017.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 1 or 3 of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Voyager Therapeutics, Peptimmune, Alnylam Pharmaceuticals. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Genetics.
The fund was created by George Whitesides, Sheridan Snyder.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Genzyme, startups are often financed by MPM Capital, Vanguard Ventures, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Vanguard Ventures, Sofinnova Investments. In the next rounds fund is usually obtained by MPM Capital, Silicon Valley Bank, New Enterprise Associates.
Related Funds
Fund Name | Location |
Agile Venture Capital | California, San Francisco, United States |
Arba Seed Investment Group | California, San Francisco, United States |
Do Ventures | Jamaica, Saint James, Vietnam |
Eminence Ventures | China, Shanghai |
Innovative Medical Management | Anaheim, California, United States |
L1 Digital | Switzerland, Zürich, Zurich |
Lytical Ventures | New York, New York, United States |
Madison Alley Global Ventures | New York, New York, United States |
P5 Health Ventures | Connecticut, Fairfield, United States |
Project Music | Nashville, Tennessee, United States |
Shalom Equity Fund | - |
Shanghai International Group (SIG) | China, Shanghai |
Spectre | California, Irvine, United States |
SRM Holdings | - |
Star Mica | Japan, Tokyo |
Xi'an Investment Holding | China, Hunan, Xian |
Xinyu Renzhi Touzi Guanli Zhongxin | China, Jiangxi, Xinyu |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
2AF Stores | $12M | 07 Jun 2006 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
2AF Stores | $12M | 07 Jun 2006 | Cambridge, Massachusetts, United States |